A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Opko Health, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 673,000 shares of OPK stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
673,000
Previous 584,400 15.16%
Holding current value
$1.06 Million
Previous $730,000 37.26%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.21 - $1.68 $2.61 Million - $3.62 Million
2,157,341 Added 626.53%
2,501,674 $3.73 Million
Q2 2024

Aug 14, 2024

BUY
$1.21 - $1.42 $146,345 - $171,744
120,947 Added 54.14%
344,333 $430,000
Q1 2024

May 15, 2024

SELL
$0.87 - $1.57 $161,093 - $290,709
-185,165 Reduced 45.32%
223,386 $268,000
Q4 2023

Feb 14, 2024

BUY
$1.23 - $1.63 $244,720 - $324,304
198,960 Added 94.93%
408,551 $616,000
Q3 2023

Nov 14, 2023

BUY
$1.5 - $2.17 $44,980 - $65,071
29,987 Added 16.7%
209,591 $335,000
Q2 2023

Aug 14, 2023

SELL
$1.37 - $2.17 $115,933 - $183,631
-84,623 Reduced 32.03%
179,604 $389,000
Q1 2023

May 15, 2023

SELL
$1.06 - $1.61 $860,086 - $1.31 Million
-811,402 Reduced 75.44%
264,227 $385,000
Q4 2022

Feb 14, 2023

BUY
$1.05 - $2.01 $236,692 - $453,096
225,421 Added 26.51%
1,075,629 $1.34 Million
Q3 2022

Nov 14, 2022

SELL
$1.81 - $2.81 $355,140 - $551,350
-196,210 Reduced 18.75%
850,208 $1.61 Million
Q2 2022

Aug 15, 2022

BUY
$2.33 - $3.61 $1.75 Million - $2.71 Million
749,800 Added 252.78%
1,046,418 $2.65 Million
Q1 2022

May 16, 2022

SELL
$2.87 - $4.93 $1.53 Million - $2.62 Million
-531,447 Reduced 64.18%
296,618 $1.02 Million
Q4 2021

Feb 14, 2022

BUY
$3.52 - $5.15 $2.17 Million - $3.17 Million
616,393 Added 291.2%
828,065 $3.98 Million
Q3 2021

Nov 15, 2021

SELL
$3.44 - $4.24 $276,090 - $340,298
-80,259 Reduced 27.49%
211,672 $773,000
Q2 2021

Aug 16, 2021

BUY
$3.33 - $4.55 $39,663 - $54,195
11,911 Added 4.25%
291,931 $1.18 Million
Q1 2021

May 17, 2021

BUY
$4.19 - $5.99 $434,000 - $620,444
103,580 Added 58.71%
280,020 $1.2 Million
Q4 2020

Feb 16, 2021

SELL
$3.27 - $4.87 $3.05 Million - $4.55 Million
-933,777 Reduced 84.11%
176,440 $697,000
Q3 2020

Nov 16, 2020

SELL
$2.99 - $5.96 $20.1 Million - $40.1 Million
-6,733,412 Reduced 85.85%
1,110,217 $4.1 Million
Q2 2020

Aug 14, 2020

BUY
$1.15 - $3.41 $8.95 Million - $26.5 Million
7,781,061 Added 12436.17%
7,843,629 $26.7 Million
Q1 2020

May 15, 2020

SELL
$1.34 - $2.32 $113,795 - $197,019
-84,922 Reduced 57.58%
62,568 $83,000
Q4 2019

Feb 14, 2020

SELL
$1.42 - $2.17 $119,514 - $182,638
-84,165 Reduced 36.33%
147,490 $217,000
Q3 2019

Nov 14, 2019

SELL
$1.75 - $2.47 $20,956 - $29,578
-11,975 Reduced 4.92%
231,655 $484,000
Q2 2019

Aug 14, 2019

SELL
$1.79 - $2.61 $3.41 Million - $4.98 Million
-1,906,897 Reduced 88.67%
243,630 $594,000
Q1 2019

May 15, 2019

BUY
$2.42 - $3.83 $4.12 Million - $6.52 Million
1,702,320 Added 379.81%
2,150,527 $0
Q4 2018

Feb 14, 2019

SELL
$2.46 - $3.87 $258,331 - $406,400
-105,013 Reduced 18.98%
448,207 $1.35 Million
Q3 2018

Nov 13, 2018

BUY
$3.29 - $6.29 $334,875 - $640,233
101,786 Added 22.55%
553,220 $0
Q2 2018

Aug 10, 2018

BUY
$2.99 - $4.99 $312,792 - $522,018
104,613 Added 30.16%
451,434 $0
Q1 2018

May 11, 2018

SELL
$3.11 - $5.12 $345,866 - $569,400
-111,211 Reduced 24.28%
346,821 $1.1 Million
Q4 2017

Feb 09, 2018

BUY
$4.61 - $7.04 $1.84 Million - $2.81 Million
399,711 Added 685.36%
458,032 $2.24 Million
Q3 2017

Nov 09, 2017

BUY
$5.88 - $7.11 $342,927 - $414,662
58,321
58,321 $400,000

Others Institutions Holding OPK

About OPKO HEALTH, INC.


  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $1.22B
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.